VANCOUVER, BC / ACCESSWIRE / September 29, 2015 / American CuMo Mining Corporation (TSXV: MLY) (OTC Pink: MLYCF) (“CuMoCo” or the “Company”) is pleased to announce a non-brokered private placement of up to 10,000,000 units (the “Units”) at a price of Cdn$0.08 per Unit for gross proceeds of up to $800,000 (the “Offering”). Funds will be used for general working capital ($400,000) and to fund ongoing work on the Company’s CuMo porphyry molybdenum-copper-silver project located in Idaho (the “CuMo Project”) ($400,000). Each Unit will consist of one common share of the Company and one share purchase warrant (a “Warrant”) exercisable to purchase one common share of the Company at a price of Cdn$0.15 per common share for a period of five years from the date of issue, subject to an acceleration provision whereby the term of the Warrants may be accelerated in the event that the Company’s common shares trade at or above a price of Cdn$0.175 per share for a period of 10 consecutive trading days. In such case, the Company may give notice to the holders of Warrants that the Warrants will expire 20 days from the date of providing such notice.

The Offering shall include two parts: a private placement to existing shareholders of CuMoCo (the “Existing Shareholder Private Placement”) under a new prospectus exemption process as set out in British Columbia Instrument 45-534 (and in similar instruments in other provinces of Canada except for Ontario and Newfoundland and Labrador) and a non-brokered private placement to all other eligible investors in accordance with applicable TSX Venture Exchange rules and securities laws (the “Concurrent Offering”).

Existing shareholders of CuMoCo are encouraged to participate in the proposed Existing Shareholder Private Placement and are invited to contact CuMoCo by email at info@cumoco.com or by telephone at +1 (604) 689-7902, for additional information. Only CuMoCo shareholders who, as of the close of business on September 25, 2015, held common shares of CuMoCo and continue to hold common shares at the time of closing may participate in the Existing Shareholder Private Placement. Unless the CuMoCo shareholder is a person that has obtained advice regarding the suitability of the investment and, if such shareholder is resident in a jurisdiction of Canada, that advice has been obtained from a person that is registered as an investment dealer in such jurisdiction, the aggregate subscription cost to such shareholder for the Units subscribed under the Existing Shareholder Private Placement cannot exceed $15,000 (187,500 Units). Existing shareholders who are residents of the Provinces of Alberta, British Columbia, Manitoba, New Brunswick, Nova Scotia, Prince Edward Island, Québec, Saskatchewan, Yukon, Northwest Territories and Nunavut may participate in the Existing Shareholder Private Placement and existing shareholders resident in countries other than Canada may need to meet the applicable eligibility requirements, if any, in their jurisdiction of residence to participate. Shareholders resident in Ontario and Newfoundland and Labrador are not permitted to participate in the Existing Shareholder Private Placement.

The maximum offering under the Existing Shareholder Private Placement shall be the balance of the Offering not sold through the Concurrent Offering to institutional and eligible accredited investors and no minimum number of Units and minimum dollar amount raised has been set. If the aggregate subscriptions for Units under the Existing Shareholder Private Placement exceed the maximum number of Units proposed to be distributed, subscriptions will be accepted on a first come, first served basis such that it is possible that a subscription received from a shareholder may not be accepted by the Company if the Offering is over-subscribed, The Board of Directors will decide on whether or not to increase the size of the placement to accommodate the over subscription. The terms and completion of the Offering are subject to TSX Venture Exchange approval.

The securities offered pursuant to the Offering have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any United States state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons absent registration or any applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release shall not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

UPDATE ON CUMO PROJECT

The Company announces that the Supplemental Environmental Assessment being prepared for the CuMo Project is nearing completion, which will enable the Company to complete its exploration program. The US Forest Service has delivered replies to all objections filed by opposition groups and the Company is awaiting the delivery of the final Decision Notice.

The Company has also decided to investigate the possibilities of applying ore sorting techniques to the CuMo Project. Ore sorting allows for the separation of the material that contains the grade from the waste. Given that only approximately 10 to 20% of the actual rock at the CuMo Project contains the grade, the Company believes that ore sorting has excellent potential to substantially reduce costs, both capital and operating, for the project. The investigation will begin with the collection of samples for analysis during the last week of September and should take a few months to complete. An independent engineering firm will complete a National Instrument 43-101 compliant report on the ore-sorting results.

Discussions continue with potential financing partners on funding the full feasibility study for the CuMo Project.

Mr. Shaun M. Dykes, M.Sc. (Eng), P.Geo., President and CEO of the Company, is the designated qualified person for the CuMo Project, and prepared the technical information contained in this news release.

About CuMoCo

CuMoCo is focused on advancing its CuMo Project towards feasibility and establishing itself as one of the largest and lowest-cost molybdenum producers in the world, as well as a significant producer of copper and silver. Management is continuing to build a strong foundation from which to move the Company and the CuMo Project forward. For more information, please visit www.cumoco.com and www.cumoproject.com.

American CuMo Mining Corporation
Shaun Dykes, President and Chief Executive Officer
Tel: (604) 689-7902
Email: info@cumoco.com

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this new release.

Forward-looking information

This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation including, but not limited to, statements that address activities, events or developments that the Company expects or anticipates will or may occur in the future, such the Company’s ability to move its CuMo Project to feasibility and production, and to become one of the largest and lowest-cost molybdenum producers in the world as well as a significant producer of copper and silver. Forward-looking information is based on a number of material factors and assumptions, including the result of exploration activities, the ability of the Company to raise the financing for a feasibility study and to put the CuMo project into production, that no labour shortages or delays are experienced, that plant and equipment function as specified that the Court will not intervene with the Company’s proposed exploration activities at the CuMo Project, and the ability of the Company to obtain all requisite permits and licenses to advance the CuMo Project and eventually bring it into production. Forward-looking information involves known and unknown risks, future events, conditions, uncertainties and other factors which may cause the actual results, performance or achievements to be materially different from any future prediction, projection or forecast expressed or implied by the forward-looking information. Such factors include, among others, the interpretation and actual results of current exploration activities; changes in project parameters as plans continue to be refined; future prices of molybdenum, silver and copper; possible variations in grade or recovery rates; labour disputes and other risks of the mining industry; delays in obtaining governmental approvals or financing, as well as those factors disclosed in the Company’s publicly filed documents, including the Company’s Management’s Discussion and Analysis for the period ended March 31, 2015. There may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information.

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

SOURCE: American CuMo Mining Corporation

ReleaseID: 432301

LAS VEGAS, NV / ACCESSWIRE / September 29, 2015 / Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) a pharmaceutical research and development company with its proprietary skin delivery technology Invisicare(R), today announced that it has expanded its patent portfolio with a new patent granted by the United States Patent and Trademark Office entitled, “ACNE TREATMENT COMPOSITION AND METHODS FOR USING.”

“This patent is an important component of Skinvisible’s comprehensive intellectual property portfolio which includes sixteen patents that provide protection in the US and major international markets up to the year 2030. The granting of this patent recognizes the unique qualities of our Invisicare delivery technology. With the acne market generating over $5 billion in the U.S. last year, this new patent further enhances the value of our pipeline of products,” said Mr. Terry Howlett, President. “We are actively seeking a partner to license and advance the clinical development of our acne formulations and other prescription dermatology products.”

All Skinvisible formulations are protected by its Invisicare patents. Invisicare is a polymer delivery system with a unique mode of delivery. It is a high performance technology that improves how products are delivered to the skin. It improves the release of actives, the binding of the product, efficacy, safety and consumer satisfaction, allowing for a potential non-inferiority claim using a lower concentration of the active as compared to the market leaders. The Invisicare pipeline includes acne (adapalene, retinoic acid, and clindamycin), actinic keratosis (imiquimod), anti-fungals (naftifine, terbinafine) plus others including an orphan drug candidate.

Demand for a patent protected pipeline of dermatology products is growing rapidly as the global medical dermatology market continues to expand and new molecules are not available. Companies are seeking products that are cost-effective and have patent protection to maximize exclusivity. Many companies prefer 505(b)(2) NDA approvals from the FDA due to lower costs and shorter approval times. A 505(b)(2) is a drug approval for a product which contains an active similar to a product already approved; eliminating repetition of some / all studies. This results in a shorter, less costly drug development process which allows the product to go to market quicker and at a lower cost. Additionally, 505(b)(2) products may receive 3 to 7 years of market exclusivity in addition to the Invisicare patent protection.

Skinvisible Inc. is a science-based research and development company with a patented skin delivery technology Invisicare(R), the foundation to every prescription (Rx), over-the-counter (OTC) and cosmeceutical product developed by the Company. Skinvisible continues to build its worldwide patent portfolio while seeking licensees for its prescription line of dermatology focused products. Through its wholly-owned subsidiary Kintari it markets cosmeceutical products and some popular OTC products such as sunscreens. The Company has sixteen patents worldwide and a portfolio of over forty products ready to be licensed or introduced to the marketplace.

About Skinvisible Pharmaceuticals, Inc.

Skinvisible Pharmaceuticals is a research-and-development company that licenses its proprietary formulations made with Invisicare, its patented polymer delivery system that offers life-cycle management and unique enhancements for topically delivered products. Invisicare holds active ingredients on the skin for extended periods of time resisting both wash off and perspiration along with controlling the release of actives and reducing skin irritation. Skinvisible’s value also lies in its ability to continually generate new IP on topical products formulated with Invisicare. In addition, Skinvisible’s wholly-owned subsidiary Kintari will commercialize its cosmeceutical and OTC product line globally through independent distributors. www.skinvisible.com, www.invisicare.com, www.kintari.com

Forward-Looking Statements: This press release contains ‘forward looking’ statements within the meaning of Section 21A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbors created thereby. Such statements involve certain risks and uncertainties associated with an emerging company. Actual results could differ materially from those projected in the forward looking statements as a result of risk factors discussed in Skinvisible, Inc. reports on file with the U.S. Securities and Exchange Commission (including, but not limited to, a report on Form 10Q for the quarter ending June 30th, 2015).

Contact:

Doreen McMorran, Skinvisible Inc.
Email: info@skinvisible.com

SOURCE: Skinvisible Inc.

ReleaseID: 432281

WILMINGTON, DE / ACCESSWIRE / September 29, 2015 / Redux Holdings, Inc. (PINKSHEETS: RDXH) is pleased to announce the Q3 shareholder call. It will be held on October 28, 2015 at 3:00 PM EST. The dial in number is (712) 775-7031 and the access code is 146-806-642. The call will be recorded.

The Company president and CEO, Mr. Alex Leo goes on to say “Every quarter our company is given the opportunity to discuss our company’s accomplishments to its shareholders and we pride ourselves on this open source of communication.”

Due to conference call time restraints, only questions that are emailed to the company in advance will be responded to. Please send any questions through email by Oct 23, 2015:

Pacific Equity Alliance LLC has been retained by Redux Holdings Inc. (PINKSHEETS: RDXH) to perform corporate consulting services over a one year period in 2015 into 2016.

President of Pacific Equity Zachary R. Logan states, “Our firm is thrilled to be working in tandem with Redux Holdings Inc. After careful due diligence and consideration from management we feel Redux Holdings Inc. has tremendous future growth in fundamental developments and upside potential in 2015 into 2016. Our firm believe there is significant fundamental & intrinsic developments in store for Redux Holdings. in 2015 / 2016 & we welcome any and every shareholder of Redux to contact myself or any one of our representatives on behalf of the company.”

Alexander Woods-Leo, President of Redux Holdings Inc, says, “The Company looks forward to the added value in combining forces with Pacific Equity. We also look long term to having a strong team dedicated in building a diversified & expanding public company though out 2015 & 2016.”

The contract is for a 12 month period with the opportunity for an extension.

Disclaimer:

Pacific Equity Alliance, LLC. is an Independent Investor Relations firm that provides information on selected publicly trade d companies. Pacific Equity Alliance, LLC. is not a United States Securities Dealer or Broker or United States registered Investment Adviser. This email letter and any and all attachments and related documents are never considered to be solicitation for any purpose in any form or content. Pacific Equity Alliance, LLC.’s Affiliates, Officers, Directors and Employees will buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own due diligence before investing in any of the stocks mentioned above. Upon receipt of these documents you, as the Recipient, hereby acknowledge this Warning and Disclaimer. These Confidential communications are protected under Gramm-Leach-Bailey Act 15 USC, Sub chapter 1, sections 6801-6809 and other laws addressing the disclosure of Non-Public Personal Information.

Press Release Information:

Investor Relations: PACIFIC EQUITY ALLIANCE LLC
Investor Contact(s): Zachary R. Logan / Drew S. Phillips
Contact phone: 858.886.7237 info@pacif8ificequityusa.com
ZL 858.776.7939

Forward-Looking Statements:

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.

Contact:
Redux Holdings, Inc.
(302) 235-3141
ir@leotekholdings.com
ZL 858.776.7939

SOURCE: Redux Holdings, Inc.

ReleaseID: 432254

Please Visit http://www.peerlogix.com; Click Investor Relations Tab

NEW YORK, NY / ACCESSWIRE / September 29, 2015 / PeerLogix, Inc. (the “Company”) (OTCQB: LOGX), an advertising technology and data aggregation provider, has posted updated investor information on its website: http://www.peerlogix.com. An updated Investor Powerpoint Presentation and Executive Summary have been added to its Investors Relations Tab, at: http://www.peerlogix.com/presentations/.

William Gorfein, Co-founder and CEO of PeerLogix, stated, “As we enter the final few months of 2015, we are pleased with our progress thus far in 2015 as we near our commercial launch in the next month. We are even more excited about our prospects going into 2016, as we look to add strategic acquisitions on top of our organic growth from penetrating our market opportunity in advertising techology. In our continued efforts to communicate and be as transparent as possible with shareholders and the Wall Street community, we have and will continue to provide updated information on our website and through press releases.”

About PeerLogix

PeerLogix is a data aggregation company providing a proprietary software as a service, or SAAS, platform which enables the tracking and cataloguing of Torrent files and Torrent networks in order to determine consumer trends and preferences based upon media consumption. PeerLogix’s patent pending platform collects Torrent data, including IP addresses of the uploading and downloading parties (e.g., location), the name, file type, media type (whether movie, television, documentary, music, e-books, software, etc.), and genre of media downloaded, and utilizes licensed and publicly available demographic and other databases to further filter the collected data to provide insights into consumer preferences to digital advertising firms, product and media companies, entertainment studios and others.

Torrent is a geography agnostic platform used by approximately 130 million people worldwide to share TV shows, movies, music, pictures, video games, e-books and software with one another. All major entertainment and media content is available to consumers using Torrent to access media. Of this population of Torrent users, approximately 40 million reside in the United States and 90 million are distributed throughout all major and developing countries of the world.

Torrent activity represents one of the most significant categories of global Internet usage, comprising approximately 22% of all Internet traffic. Although Torrent data available at any one point in time is ephemeral and is then lost, PeerLogix has been storing and continues to store all such data in a fully scalable database which has been aggregating the results since approximately January 1, 2014, providing the distinctive ability to provide trend data on the basis of media consumption. The Company’s proprietary platform operates on an automatic basis with little human interaction and continually acquires and catalogues Torrent data in real time, obtaining millions of data points daily.

Forward Looking Statement

Certain of the statements contained in this herein include future expectations, contain projections of results of operations or financial condition or state other “forward-looking” information. The information contained in this includes some statements that are not purely historical and contain “forward-looking statements,” as defined by the Private Securities Litigation Reform Act of 1995,that involve risks and uncertainties. Such forward-looking statements include, but are not limited to, statements regarding the Company’s and its management’s expectations, hopes, beliefs, intentions or strategies regarding the future, including the Company’s financial condition and results of operations. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “believe,” “expect,” “anticipate,” “intend,” “estimate,” “may,” “should,” “could,” “will,” “plan,” “future,” “continue,” and other expressions that are predictions of or indicate future events and trends and that do not relate to historical matters identify forward-looking statements. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, the actual results could differ materially from the forward-looking statements contained in PeerLogix forward-looking statements.

Contact:

William Gorfein
Chief Executive Officer
PeerLogix, Inc.
646-598-4640
info@peerlogix.com

SOURCE: PeerLogix, Inc.

ReleaseID: 432286

Medbox Initiates Search for Successor

LOS ANGELES, CA / ACCESSWIRE / September 29, 2015 / Medbox, Inc. (OTCQB: MDBX), a provider of specialized services to the cannabis sector, including operators of dispensaries, cultivation centers, manufacturers and research facilities in those states where approved, today announced that Jennifer Love is relinquishing her post as a member of the company’s Board of Directors because of time constraints and new professional obligations as a result of her relocation.

Medbox said it has initiated a search for a successor to serve on its board.

“We wish Jennifer all the best in her new endeavor and extend appreciation for her many contributions to Medbox during the company’s successful transformation,” said Ambassador Ned L. Siegel, Medbox Chairman of the Board.

“My time on the board has been an incredible experience,” said Love. “I am gratified that today’s Medbox is in great hands and on a positive trajectory.”

Current directors of Medbox include Ambassador Siegel, who has been appointed interim Chairman of the Audit Committee, and J. Mitchell Lowe, co-founder of Netflix and former Redbox President.

About Medbox, Inc.

Medbox, Inc., a leader in the rapidly emerging cannabis sector, provides specialized services to operators of dispensaries, cultivation centers, manufacturers and research facilities in those states where approved. Through trusted clients and affiliates, the company promotes efficient, consistent, high quality products that are priced right, readily available and safely packaged. For more information about the company or to explore partnership, please visit www.medbox.com.

Forward-Looking Statements

Certain statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements, including, but not limited to, filling the the vacancy on the company’s board, are based on current beliefs and expectations and are inherently subject to significant business, economic, regulatory and competitive uncertainties and contingencies, many of which are beyond the company’s control. In addition, certain forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties also include, but are not limited to, regulatory developments in the industry, as well as political and economic conditions present within the industry. For a more detailed description of the risk factors associated with the company, please refer to the company’s latest Annual Report on Form 10-K, and in particular, the section entitled “Risk Factors” therein, and in other periodic reports the company files with the Securities and Exchange Commission thereafter. The company does not assume any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made, unless required by law.

For more information, contact:

Janet Simmons
PondelWilkinson Inc.
310-279-5980
pwinvestor@pondel.com

SOURCE: Medbox, Inc.

ReleaseID: 432268